Back to results
Active, not recruitingPhase 4

12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease

NCT07034222

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

View on ClinicalTrials.gov
12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease — TrialFind